News Banner

MaxQ News

Posts about FDA news:

MaxQ AI leads AI security with ISO 27799 certification for health informatics

MaxQ Dec 2, 2020 5:45:00 PM

Information Security and ISO 27001 Recertification

New healthcare information security certification demonstrates commitment to the highest standards of data protection across the company’s operations, systems, and products.

Tel Aviv, Israel – December 2nd, 2020 – MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today that after undergoing stringent reviews by the British Standards Institution (BSI), it has achieved ISO 27799 certification and ISO 27001 recertification. Both certifications are widely recognized international standards for information security management systems. These standards separate MaxQ in its commitment to deploying the Accipio Clinical Platform as a comprehensive, seamless, and secure solution for the healthcare industry.

MaxQ AI Receives FDA Clearance for Accipio Ix™

MaxQ Nov 7, 2018 4:18:00 PM

FDA Clearance for Accipio Ix™ Intracranial Hemorrhage Platform

Agreement will pave the way for integration of MaxQ AI’s artificial intelligence Accipio Ix™ intracranial hemorrhage software into NeuroLogica’s medical imaging platforms in the U.S. and E.U. acute care market

Tel Aviv, Israel and Andover, MA – November 7, 2018 – MaxQ AI, a clinical diagnostics intelligence platform company, today announced that its revolutionary Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance paves the way for healthcare providers and physicians in acute care settings to have access to this artificial intelligence (AI) software designed to aid in prioritizing the clinical assessment of adult non-contrast head computed tomography (CT) cases that exhibit indications of intracranial hemorrhage (ICH), commonly known as a brain bleed.

MedyMatch Technology Announces Name Change to MaxQ AI

MaxQ Mar 18, 2018 4:47:00 PM
Tel Aviv, Israel March 18, 2018 – MedyMatch Technology, a company focused on assisting physicians provide accurate patient assessment through artificial intelligence-based insights, (which recently received FDA Breakthrough Designation for its intracranial hemorrhage (ICH) detection application), announced today an exciting new phase in its growth with the launch of its new corporate identity as MaxQ AI.